EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation

Luca Cumitini iD, Giulia Renda iD, Mara Giordano iD, Roberta Rolla iD, Tarek Shail, Sara Sacchetti iD, Lorena Iezzi, Luca Giacomini iD, Valentina Zanotti, Raffaella Auciello, Ilaria Angilletta, Melissa Foglietta und 6 weitere

Journal of Clinical Medicine · 26.04.2024 · 13 (9) · 2545

DOI: 10.3390/jcm13092545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.04.2024. Verfasst von Luca Cumitini und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Eastern Piedmont, 28100 Novara, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dabigatran etexilate is a pro-drug hydrolyzed into dabigatran by carboxylesterases (CES) and is a substrate of the P-Glycoprotein encoded by the adenosine-triphosphate-binding cassette sub-family B member (ABCB)1 genes. We evaluated the functional response to dabigatran according to different CES1 and ABCB1 single-nucleotide polymorphisms (SNPs) in patients with atrial fibrillation (AF).

Methods

A total of 100 consecutive patients with AF taking dabigatran were enrolled by two Italian centers. A venous blood sample was drawn for genetic determinations, as well as a measurement of the diluted thrombin time (dTT) and drug plasma concentrations, at the trough and peak. The main objective was the relationship between the dTT values and CES1 rs2244613, CES1 rs8192935 and ABCB1 rs4148738 SNP while on two different dabigatran doses (110 and 150 mg BID).

Results

A total of 43 patients were on a 110 mg dabigatran dose and 57 on 150 mg. The DTT values at the trough and at peak were not different among patients with different CES1 rs2244613 and CES1 rs8192935 genotypes, regardless of the dabigatran dose. In patients on 150 mg dabigatran, the dTT values at the trough were 77 (44–111) ng/mL in patients with the ABCB1 rs4148738 heterozygous CT genotype vs. 127 (85–147) ng/mL in the wild-type CC genotype vs. 110 (47–159) ng/mL in the mutant trait TT genotype (p = 0.048). In patients with the ABCB1 rs4148738 CT genotype, OR for having dTT values at a trough below the median was 3.21, 95% CI 1.04–9.88 (p = 0.042).

Conclusions

ABCB1 rs4148738 CT heterozygous is associated with the reduced anticoagulant activity of dabigatran at the trough in patients receiving the higher dose regimen.

Schlagwörter

Stichwörter der Autor:innen

dabigatrandiluted thrombin timegeneticsoral anticoagulantspolymorphisms

Autor:innen und Institutionen

  • Department of Translational Medicine, University of Eastern Piedmont, 28100 Novara, Italy.
  • Division of Cardiology, AOU Maggiore della Carità, 28100 Novara, Italy.
  • Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
  • Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
  • Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.
  • Clinical Biochemistry, AOU Maggiore della Carità, 28100 Novara, Italy.

ORCID-Profile: Luca Cumitini, Giulia Renda, Mara Giordano, Roberta Rolla, Sara Sacchetti, Luca Giacomini, Mirco Zucchelli, Ivana Antonucci, Sabina Gallina, Giuseppe Patti

Zitieren

APA

Cumitini, L., Renda, G., Giordano, M., Rolla, R., Shail, T., Sacchetti, S., Iezzi, L., Giacomini, L., Zanotti, V., Auciello, R., Angilletta, I., Foglietta, M., Zucchelli, M., Antonucci, I., Stuppia, L., Gallina, S., Dianzani, U., & Patti, G. (2024). Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation. Journal of Clinical Medicine, 13(9), 2545. https://doi.org/10.3390/jcm13092545

Vancouver

Cumitini L, Renda G, Giordano M, Rolla R, Shail T, Sacchetti S, et al. Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation. Journal of Clinical Medicine. 2024;13(9):2545. doi:10.3390/jcm13092545

BibTeX
@article{Cumitini2024,
  author = {Cumitini, Luca and Renda, Giulia and Giordano, Mara and Rolla, Roberta and Shail, Tarek and Sacchetti, Sara and Iezzi, Lorena and Giacomini, Luca and Zanotti, Valentina and Auciello, Raffaella and Angilletta, Ilaria and Foglietta, Melissa and Zucchelli, Mirco and Antonucci, Ivana and Stuppia, Liborio and Gallina, Sabina and Dianzani, Umberto and Patti, Giuseppe},
  title = {Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {9},
  pages = {2545},
  doi = {10.3390/jcm13092545}
}
Kostenlos starten →